Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX
Chimovits Erez bought 61,516 Adarx Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 28, 2026 · Filed Sep 30, 2026
On Sep 28, 2026, Chimovits Erez (Director) bought 61,516 Adarx Pharmaceuticals, Inc. shares at US$17.00 for US$1.05M, leaving 9,292,025 shares. Filed Sep 30, 2026 (Form 4).
- Bought
- 61,516 shares
- Price
- US$17.00
- Value
- US$1.05M
- Holding after
- 9,292,025 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Common Stock | Conversion | 7,127,019 | 7,127,019 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 1,333,975 | 8,460,994 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 513,067 | 8,974,061 | Indirect | |
| Sep 28, 2026 | Common Stock | Conversion | 256,448 | 9,230,509 | Indirect | |
| Sep 28, 2026 | Common Stock | Buy | 61,516 | US$17.00 | 9,292,025 | Indirect |
Source
Related
- Adarx Pharmaceuticals, Inc.
- Chimovits Erez
- Adarx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Yi Shi · Oct 16, 2026
- Schedule 13D · SR One Capital Management, LLC · Oct 5, 2026
- Schedule 13D · Orbimed Advisors LLC · Oct 2, 2026
- Schedule 13G · BCLS Fund III Investments, LP · Oct 1, 2026
- Form 4 · Gordon Carl L · Sep 30, 2026